Cost-Effectiveness Analysis of Oxaliplatin Plus Fluorouracil/Leucovorin (Folfox4) Compared to Sorafenib for Treatment of Advanced Hepatocellular Carcinoma Patients in China
Abstract
Authors
SK Qin E Kruger SC Tan SQ Cheng XX Yao J Liang